new version V2017

Abemaciclib CDK (cyclin-dependent kinase) inhibitor

Verzenio - LY2385219 - LY2835210 - abemaciclib      

pdf
TrialStudied treatmentControl treatmentpatientsROBResultNCT

advanced breast cancer (metastatic)

MONARCH 3, 2017Abemaciclib +nsAInsAI Low risk of bias ConclusiveNCT02246621

lung cancer (metastatic)

JUNIPER, 2018abemacicliberlotinib2nd line Risk of bias - NCT02152631